Brand vs Generic Drugs: What Clinical Research Says About Switching
Explore clinical research on switching from brand-name to generic drugs. Learn about bioequivalence, NTI drugs, and how to safely manage your medication transitions.
Tag: bioequivalence
The 80-125% Rule: Understanding Bioequivalence Confidence Intervals
The 80-125% rule determines bioequivalence between generic and brand-name drugs. Learn what this range really means for patient safety and why confidence intervals matter.
Quality by Design in Generic Drug Development: Modern Science-Based Approaches
Quality by Design (QbD) transforms generic drug development by building quality into every step of the process. Learn how modern science-based approaches improve bioequivalence, reduce regulatory delays, and cut long-term costs for generic manufacturers.